US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Innovative Solutions Ecosystem SA (0RL5) 銘柄情報

Innovative Solutions Ecosystem SA (0RL5)

0.744

0.00

(0.00%)

終了 7月11日 12:30AM

Innovative Solutions Ecosystem SA (0RL5) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.744

( - )

買値

0.744

売値

0.744

出来高

0.00

平均取引量 (3 か月)

0.00 €

財務取引量

-

0.00 日の範囲 0.00

0.744 52 週間の範囲 0.744

時価総額

企業価値

-

前日終値

0.744

始値

-

時刻

最終取引時間

VWAP

-

歳入

11.75k

純利益

-505.3k

発行済株式数

57,686,300

浮動株比率 (%)

23.90%

機関投資家保有比率 (%)

-

配当利回り

PER

-

株価売上高倍率 (PSR)

-

1 株当たり利益 (EPS)

-0

ベータ

0.15

Innovative Solutions Ecosystem, S.A. provides solutions for data management and security, cryptography and related applications, and other technologies that facilitate data security and communication between organizations and their clients and stakeholders worldwide. The company was formerly known a... Innovative Solutions Ecosystem, S.A. provides solutions for data management and security, cryptography and related applications, and other technologies that facilitate data security and communication between organizations and their clients and stakeholders worldwide. The company was formerly known as Service Point Solutions, S.A. and changed its name to Innovative Solutions Ecosystem, S.A. in November 2021. Innovative Solutions Ecosystem, S.A. was incorporated in 1969 and is headquartered in Madrid, Spain. Innovative Solutions Ecosystem, S.A. is a subsidiary of Paragon Financial Investments Limited. 詳細を表示

セクター

Industrials

業界

Commercial Services & Supplies

ウェブサイト

www.innovative-ecosystem.com

本社

Madrid, Spain

設立

1969

Innovative Solutions Ecosystem SA is listed in the Industrials sector of the ロンドン証券取引所 with ticker 0RL5. The last closing price for Innovative Solutions Eco... was 0.74 €. Over the last year, Innovative Solutions Eco... shares have traded in a share price range of 0.744 € to 0.744 €.

Innovative Solutions Eco... currently has 57,686,300 shares in issue. The market capitalisation of Innovative Solutions Eco... is 42.92 € million.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0.744	0.744	0.744	0	0	DE
52	0	0	0.744	0.744	0.744	0	0	DE
156	0	0	0.744	0.744	0.744	0	0	DE
260	0	0	0.744	0.744	0.744	6	0.744	DE

0RL5 - Frequently Asked Questions (FAQ)

What is the current Innovative Solutions Ecosystem SA share price?

The current share price of Innovative Solutions Ecosystem SA is 0.744 €

How many Innovative Solutions Ecosystem SA shares are in issue?

Innovative Solutions Ecosystem SA has 57,686,300 shares in issue

What is the market cap of Innovative Solutions Ecosystem SA?

The market capitalisation of Innovative Solutions Ecosystem SA is EUR 42.92M

What is the 1 year trading range for Innovative Solutions Ecosystem SA share price?

Innovative Solutions Ecosystem SA has traded in the range of 0.744 € to 0.744 € during the past year

What is the registered address of Innovative Solutions Ecosystem SA?

The registered address for Innovative Solutions Ecosystem SA is c/ Salcedo 6, Madrid, Madrid, 28034

What is the Innovative Solutions Ecosystem SA website address?

The website address for Innovative Solutions Ecosystem SA is www.innovative-ecosystem.com

Which industry sector does Innovative Solutions Ecosystem SA operate in?

Innovative Solutions Ecosystem SA operates in the Commercial Services & Supplies sector

rosemountbomber

rosemountbomber 16分前

It is the consensus view because company management and the FDA have not given us reason to believe otherwise. As far as the AI take in your following post how ridiculous that the 2nd CRL to cite the same deficiencies as the first. They never did a second inspection to discover those deficiencies.

Genz2

https://www.macrumors.com/2026/07/09/apple-prismml-larger-on-device-ai-models/

Has Tesla/SpaceXAI thought about working with a company like PrismML so that they could efficiently run Grok/MacroHard and use less memory in Dell, HP or Lenovo computers? The PrismML could reduce the memor

Slojab

Slojab 18分前

Pretty ridiculous, huh? You should be able to have a negative market cap. 🤣

smoki

F’ing A ….blasting off get your free ride NOW!!! $$$$$$$$$ …Blozf goos Blo ^^^^^^^^^^^^:))))))

BahamaPete

BahamaPete 27分前

Thanks OCKHAM's RAZOR, I added your links to my DD post. Go $TKOI

Helter Skelter

Helter Skelter 37分前

😆 "accurately captures one of the most critical underappreciated alliances..."

https://investorshub.advfn.com/uimage/uploads/2026/7/10/opnhmBB_Can_u_say_MONOPOLY_071026.png

🤑 $BB Where Nvidia Goes We Go $NVDA 🤑

Twiggs333

Twiggs333 43分前

CMPS Compass Pathways: A Structural Mispricing in Plain Sight?

Extremely good explanation of the value of this company by a Stanford Professor.

https://x.com/kevin__mak/status/2075541715272790373

Popeye

Popeye 44分前

Yeah, agreed. That was a shot of the dark guess of the discount for the Reg A and .08 would certainly move the numbers in the favor of the shareholder.
Unknowns are 1. What will the discount be and 2. How much will Korenko raise? (Doesn’t have to raise the entire $9 million now - maybe raise

Twiggs333

Twiggs333 45分前

Compass Pathways: A Structural Mispricing in Plain Sight?

https://x.com/kevin__mak/status/2075541715272790373

CA Market News

CA Market News 49分前

Lion One Announces Closing of Second Tranche of Non-Brokered Private Placement of Convertible Debenture Units and Units for Aggregate Gross Proceeds of $17.5 MillionJuly 10, 2026 11:14 PM
Newsfile

Genz2

Sorry, misspelled Greg’s last name in the previous post!!! It should be Kazmierczak!!

Gus1212

Gus1212 58分前

If this rejection theory is correct, I believe it was just a tactic to stall our approval process.
Sounds too simple, doesn't it!

Maybe paid for by you know who, big pharma.

They all know that DCVAX works; they are not dummies.
Why did they stall? Cou

Whalatane

Whalatane 1時間前

A Fable 5 analysis
Synthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsSynthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsGood context to layer in.
Here's the deeper risk breakdown on those three fronts.

LTR

I think a suitable punishment for these guys would be to lock them up in ILT's vault and throw away the key.

Real McCoy

Real McCoy 1時間前

Well yeah this one has the most lies.

3rd attempt: you ok with lies, yes or no?

pos_stock_hoarder

pos_stock_hoarder 1時間前

New York Dolls - Looking for a Kiss

https://youtu.be/GvmvMFXWzc8

Genz2

Genz2 1時間前

https://techcrunch.com/2026/07/10/us-cyber-agency-cisa-had-to-build-its-incident-playbook-during-the-incident-agency-reveals/

According to Krebs, the researcher tried to alert the contractor but didn’t hear back. Only after Krebs contacted CISA did the agency take the repository offli

boston127

boston127 1時間前

Hey,

Thanks for the links you sent me. My PC blocked all of the URLs due to malware protection. I'm still in GNIS and the other one. I was up but they have dive bombed quite rapidly. Now, in the RED. Both companies are interesting.

LTR

I have an idea AF may turn up in discovery when the dots are lined up and connected. AF may look to be a witness in order to avoid being a defendent.

conix

conix 1時間前

Non-promotional information until there is a press release is a wise move.

CatfishHunter

CatfishHunter 1時間前

We should have news of next step well before years end. Vivos is already approved by FDA to start the EFS. Mayo Clinic needs to review and sign off on the approved conditions for the IRB and that’s just a formality. EFS could start as early as August. And 30 day patient status report about 45 days a

Philosophical Trader

Philosophical Trader 1時間前

How is this doing? This was a great runner with a 2 year cup and handle.

nwtf

nwtf 1時間前

You really dont have a clue what you are talking about. Just stop.

Innovative Solutions Eco...

2.550% Nts 02/13/2030 Ru...

First Citizens Bancshares (EM)

Bitwise Crypto Innovator...

Tagus TEC Title Credits ...

Amundi Core MSCI Emergin...

Exchange Traded Fund Ivz...

Investec Bnk 24

Stellar AfricaGold

Hudson Acquisition I

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。